Table 1 Patient Characteristics and Treatments
Patient No. | Gender | Age | Kadish stage | LN meta | Treatment | Surgery | Chemotherapy | Radiation dose |
|---|---|---|---|---|---|---|---|---|
1 | F | 22 | B | – | Surgery + PostopRT | TR | – | 65Gy/26Fr |
2 | M | 59 | B | – | Surgery + PostopRT | PR | – | 60Gy/30Fr |
3 | F | 72 | B | – | Surgery + PostopRT | STR | – | 50Gy/25Fr |
4 | M | 53 | C | – | Surgery + PostopRT | STR | – | 56Gy/28Fr |
5 | F | 66 | C | RPN | Surgery + PostopRT | TR | – | 65Gy/26Fr |
6 | M | 63 | C | – | PreopRT + Surgery | – | 40Gy/20Fr | |
7 | M | 55 | C | – | NAC + Surgery + PostopRT | STR | ICE 1 cycle | 65Gy/26Fr |
8 | F | 71 | C | – | NAC + Surgery + PostopRT | TR | ICE 1 cycle | 60Gy/30Fr |
9 | F | 43 | C | – | NAC + Surgery + PostopRT | TR | ICE 5 cycle | 60Gy/30Fr |
10 | M | 37 | C | – | NAC + Surgery + PostopRT | TR | ICE 5 cycles | 60Gy/30Fr |
11 | M | 66 | C | – | NAC + Surgery + PostopRT | TR | CDDP | 60Gy/24Fr |
12 | F | 44 | C | – | NAC + Surgery + PostopRT | STR | CDDP + ETP | 60Gy/30Fr |
13 | M | 46 | C | – | Surgery + Chemo + PostopRT | PR | ICE 2 cycles | 66Gy/33Fr |
14 | M | 24 | C | – | NAC + definitive RT | – | CADO/CVP 3 cycle | 54Gy/27Fr |
15 | F | 67 | C | ILCN | NAC + definitive RT | – | ICE 2 cycles | 66Gy/33Fr |
16 | M | 70 | C | – | NAC + definitive RT | – | CDDP 1 cycles + ICE 2 cycles | 65Gy/26Fr |
17 | M | 76 | C | – | definitive RT + Chemo | – | ICE 2 cycles | 65Gy/26Fr |